Get the Stockscreener App
0.493
4.09%
-0.021
After Hours:
.51
0.017
+3.45%
Quoin Pharmaceuticals Ltd Adr stock is traded at $0.493, with a volume of 189.75K.
It is down -4.09% in the last 24 hours and down -21.26% over the past month.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
See More
Previous Close:
$0.514
Open:
$0.52
24h Volume:
189.75K
Relative Volume:
0.43
Market Cap:
$1.93M
Revenue:
-
Net Income/Loss:
$-8.69M
P/E Ratio:
-0.0107
EPS:
-45.9343
Net Cash Flow:
$-7.86M
1W Performance:
-3.45%
1M Performance:
-21.26%
6M Performance:
-48.11%
1Y Performance:
-88.12%
1-Day Range:
$0.481
$0.52
1-Week Range:
$0.481
$0.5498
52-Week Range:
$0.4772
$6.18
Quoin Pharmaceuticals Ltd Adr Stock (QNRX) Company Profile
Name
Quoin Pharmaceuticals Ltd Adr
Sector
Industry
Phone
97299741444
Address
23 HATA'AS STREET, KFAR SABA
Quoin Pharmaceuticals Ltd Adr Stock (QNRX) Latest News
Balance Sheet Insights: Quoin Pharmaceuticals Ltd ADR (QNRX)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Quoin Pharmaceuticals CFO buys shares worth over $23,000 - Investing.com
Healthy Upside Potential: Quoin Pharmaceuticals Ltd ADR (QNRX) - SETE News
A closer look at QNRX’s price-to-free cash flow ratio - US Post News
Quoin Pharmaceuticals COO acquires $28,737 in company shares - Investing.com
Quoin Pharmaceuticals COO acquires $28,737 in company shares - Investing.com India
Quoin Pharmaceuticals (NASDAQ:QNRX) Stock Quotes, Forecast and News Summary - Benzinga
QNRX Stock Hits 52-Week Low at $0.57 Amid Market Challenges - Investing.com Australia
QNRX Stock Hits 52-Week Low at $0.57 Amid Market Challenges - Investing.com India
QNRX Stock Hits 52-Week Low at $0.57 Amid Market Challenges - Investing.com
Quoin Pharmaceuticals to Sponsor the Foundation for Ichthyosis & Related Skin Types (FIRST) 2024 National Conference - GlobeNewswire Inc.
Quoin Pharmaceuticals partners with UCC for drug delivery tech By Investing.com - Investing.com
Quoin Pharmaceuticals Announces Signing of Research Agreement with University College Cork (UCC), Ireland - GlobeNewswire Inc.
Quoin Pharmaceuticals director Dennis Langer sells shares worth $217 - Investing.com India
Quoin Pharmaceuticals director Dennis Langer sells shares worth $217 By Investing.com - Investing.com
Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2024 Financial Results - Investing.com South Africa
Quoin Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 9, 2024 - GlobeNewswire Inc.
symbol__ Stock Quote Price and Forecast - CNN
GLMD Stock Quote Price and Forecast - CNN
U.S. shares lower at close of trade; Dow Jones Industrial Average down 1.04% - Investing.com India
Quoin Pharmaceuticals (QNRX) Stock Price, News & Analysis - MarketBeat
ADVFNFree stock and cryptocurrency prices, charts, market news and streaming real-time quotes. - ADVFN
Quoin Pharmaceuticals Ltd Adr Stock (QNRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):